Extraperitoneal Laparoscopic Radical ProstatectomyResults after 50 Cases R Bollens, M Vanden Bossche, T Roumeguere, A Damoun, S Ekane, ... European urology 40 (1), 65-69, 2001 | 385 | 2001 |
Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk TH Roumeguere, E Wespes, Y Carpentier, P Hoffmann, CC Schulman European urology 44 (3), 355-359, 2003 | 320 | 2003 |
Trans-obturator vaginal tape (TOT®) for female stress incontinence: one year follow-up in 120 patients T Roumeguère, TH Quackels, R Bollens, A De Groote, A Zlotta, ... European urology 48 (5), 805-809, 2005 | 207 | 2005 |
Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approaches T Roumeguere, R Bollens, M Vanden Bossche, D Rochet, D Bialek, ... World Journal of Urology 20, 360-366, 2003 | 198 | 2003 |
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up A Lemy, KM Wissing, S Rorive, A Zlotta, T Roumeguere, MCM Martinez, ... American Journal of Kidney Diseases 51 (3), 471-477, 2008 | 118 | 2008 |
Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies C Delporte, P Van Antwerpen, L Vanhamme, T Roumeguère, ... Mediators of inflammation 2013, 2013 | 115 | 2013 |
Laparoscopic partial nephrectomy with “on-demand” clamping reduces warm ischemia time R Bollens, A Rosenblatt, BP Espinoza, A De Groote, T Quackels, ... european urology 52 (3), 804-810, 2007 | 106 | 2007 |
COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor G Mjaess, A Karam, F Aoun, S Albisinni, T Roumeguère Progrès en urologie 30 (10), 484-487, 2020 | 102 | 2020 |
Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield B Djavan, AR Zlotta, S Ekane, M Remzi, G Kramer, T Roumeguere, ... European urology 38 (2), 218-224, 2000 | 100 | 2000 |
Laparoscopic radical prostatectomy: the learning curve R Bollens, S Sandhu, T Roumeguere, T Quackels, C Schulman Current opinion in urology 15 (2), 79-82, 2005 | 89 | 2005 |
Silodosin in the treatment of benign prostatic hyperplasia M Rossi, T Roumeguère Drug design, development and therapy, 291-297, 2010 | 72 | 2010 |
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non–muscle-invasive bladder cancer AR Zlotta, T Roumeguere, C Kuk, S Alkhateeb, S Rorive, A Lemy, ... European urology 59 (6), 1026-1031, 2011 | 66 | 2011 |
Use of statins and outcome of BCG treatment for bladder cancer P Hoffmann, T Roumeguère, C Schulman, R Van Velthoven New England Journal of Medicine 355 (25), 2705-2707, 2006 | 65 | 2006 |
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy?: A multivariate analysis on 1283 patients AR Zlotta, T Roumeguère, V Ravery, P Hoffmann, F Montorsi, L Türkeri, ... European urology 46 (1), 42-49, 2004 | 59 | 2004 |
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy R Diamand, M Oderda, W Al Hajj Obeid, S Albisinni, R Van Velthoven, ... World Journal of Urology 37, 2109-2117, 2019 | 55 | 2019 |
Urgency and other lower urinary tract symptoms in men aged≥ 40 years: a Belgian epidemiological survey using the ICIQ‐MLUTS questionnaire D De Ridder, T Roumeguere, L Kaufman International journal of clinical practice 69 (3), 358-365, 2015 | 55 | 2015 |
The place of surgery for vascular impotence in the third millennium E Wespes, T Wildschutz, T Roumeguere, CC Schulman The Journal of urology 170 (4), 1284-1286, 2003 | 54 | 2003 |
Implementation of closed-loop-assisted intra-operative goal-directed fluid therapy during major abdominal surgery: a case–control study with propensity matching A Joosten, S Coeckelenbergh, A Delaporte, B Ickx, J Closset, ... European Journal of Anaesthesiology| EJA 35 (9), 650-658, 2018 | 51 | 2018 |
Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy? AS Merseburger, P Hammerer, F Rozet, T Roumeguère, O Caffo, ... World journal of urology 33, 1079-1085, 2015 | 49 | 2015 |
The importance of measuring the prostatic transition zone: an anatomical and radiological study Zlotta, Djavan, Damoun, Roumeguere, Petein, Entezari, Marberger, ... BJU international 84 (6), 661-666, 1999 | 47 | 1999 |